Targeting Thymidylate Kinase for Chronic Myeloid Leukemia Eradication

Targeting Thymidylate Kinase for Chronic Myeloid Leukemia Eradication

碩士 === 國立陽明大學 === 生化暨分子生物研究所 === 104

Bibliographic Details
Main Authors:	Ying-Hsuan Chung, 鍾映玄
Other Authors:	Zee-Fen Chang
Format:	Others
Language:	zh-TW
Published:	2016
Online Access:	http://ndltd.ncl.edu.tw/handle/02504127198255583238

Similar Items

Assessment of a potential therapeutic target in the Hedgehog pathway for the eradication of primitive chronic myeloid leukemia cells
by: Turner, Kelly Anne
Published: (2017)

Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
by: Hu Lei, et al.
Published: (2021-01-01)

Signaling pathways involved in chronic myeloid leukemia pathogenesis: the importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells
by: Foruzan Moradi, et al.
Published: (2019-06-01)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
by: Bijender Kumar
Published: (2021-03-01)

Functional analysis of human thymidylate kinase
by: Chuan-Mei Hu, et al.
Published: (2005)

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
by: Mario Tiribelli, et al.
Published: (2019-08-01)

Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
by: Oliver Herrmann, et al.
Published: (2019-07-01)

Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
by: Solène Fernandez, et al.
Published: (2019-07-01)

Investigation into human thymidylate kinase by the yeast tool
by: Ming-Yun Hsieh, et al.
Published: (2012)

Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
by: Avital F. Barak, et al.
Published: (2011-12-01)

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
by: Miguel Carracedo, PhD, et al.
Published: (2020-03-01)

Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML)
by: C. B. Almeida, et al.
Published: (2016-11-01)

Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety
by: Valentín García-Gutiérrez, et al.
Published: (2019-07-01)

Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia
by: Stephen E. Langabeer, et al.
Published: (2020-01-01)

Cardiovascular Toxicity of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia
by: IL Davydkin, et al.
Published: (2018-10-01)

Exploration of tyrosine kinase nhibitor-mediated resistance in chronic myeloid leukemia
by: AGUSTINA BUNGAHOT, et al.
Published: (2017)

Characterization of novel therapeutic targets in chronic myeloid leukemia
by: Rothe, Katharina
Published: (2016)

Targeted treatment of chronic myeloid leukemia: role of imatinib
by: Ila Tamascar, et al.
Published: (2009-03-01)

Development and targeted use of nilotinib in chronic myeloid leukemia
by: Carmen Fava, et al.
Published: (2008-11-01)

Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
by: Ignazia Tusa, et al.
Published: (2018-10-01)

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
by: Simona Soverini, et al.
Published: (2018-02-01)

Targeting splice factor kinases in chronic myeloid leukaemia
by: Alabouh, Hanan A.
Published: (2017)

IRAK Family Kinases as Therapeutic Targets for Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Rhyasen, Garrett W.
Published: (2014)

Chronic myeloid leukemia: can tyrosine kinase inhibitors achieve a "cure"?
by: Maria Eduarda dos Santos Couto
Published: (2019)

Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment
by: Agnieszka Wieczorek, et al.
Published: (2015-01-01)

Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment
by: Agnieszka Wieczorek, et al.
Published: (2016-02-01)

Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations
by: Elisabetta Abruzzese, et al.
Published: (2020-10-01)

Features of the etythropoesis upon treatment of chronic myeloid leukemia with tyrosine kinase inhibitor
by: I. Sviezhentseva, et al.
Published: (2016-07-01)

Genotoxicity and mutagenicity in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
by: Pedro Aurio Maia Filho
Published: (2017)

Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia
by: Christian Boni, et al.
Published: (2021-05-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
by: Hélène Losson, et al.
Published: (2020-01-01)

Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy
by: KM Abdulkadyrov, et al.
Published: (2016-01-01)

RhoA: A therapeutic target for chronic myeloid leukemia
by: Molli Poonam R, et al.
Published: (2012-03-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

Design and Synthesis of Inhibitors against Human Thymidylate Kinase
by: Meng-Ruo Huang, et al.
Published: (2013)

Structural Studies on Thymidylate Kinase : Evolution, Specificity and Catalysis
by: Biswas, Ansuman
Published: (2018)

Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors
by: Jee Hyun Kong, et al.
Published: (2020-05-01)

LONG-TERM RESULTS OF TARGET THERAPY WITH FIRST AND * SECOND-LINE TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
by: L. L. Vysotskaya, et al.
Published: (2016-02-01)

Chronic Myeloid Leukemia in 2020
by: Rüdiger Hehlmann
Published: (2020-10-01)